跳至主要内容
临床试验/NCT03276897
NCT03276897已完成不适用

Efficacy and Tolerance Evaluation of a "Revitalizing" Face Treatment

Derming SRL2 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2017年3月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Derming SRL
入组人数
22
试验地点
2
主要终点
Change of skin resistance to pinching clinical score

研究概览

简要总结

Efficacy and Tolerance Evaluation of a"revitalizing" face treatment consisting of a day and a night cream

详细描述

Aim of the study was to evaluate clinically and by non-invasive instrumental evaluations the activity of a "revitalizing" face treatment consisting of a day and a night cream, applied for an uninterrupted period of 3 months, by female volunteers, aged 35-60 years, with aging/photo aging of moderate grade.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
35 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • female sex,
  • age 35-60 years,
  • Caucasian subjects,
  • presence of moderate face ritidosis,
  • agreeing to present at each study visit without make-up,
  • accepting to follow the instructions received by the investigator,
  • accepting to not change their habits regarding food, physical activity, face cleansing and make- up use,
  • agreeing not to apply or take any product or use face massages or other means known to improve skin wrinkle and skin qualities during the entire duration of the study,
  • accepting not to expose their face to strong UV irradiation (UV session, or sun bathes), during the entire duration of the study,
  • no participation in a similar study currently or during the previous 3 months
  • accepting to sign the Informed consent form.

排除标准

  • Pregnancy,
  • lactation,
  • sensitivity to the test products or their ingredients (to be assessed by the investigator during the baseline visit),
  • subjects whose insufficient adhesion to the study protocol is foreseeable.
  • presence of cutaneous disease on the tested area as lesions, scars, malformations,
  • recurrent facial/labial herpes,
  • clinical and significant skin condition on the test area (e.g. active eczema, dermatitis, psoriasis etc.).
  • endocrine disease,
  • hepatic disorder,
  • renal disorder,
  • cardiac disorder,
  • pulmonary disease,
  • neurological or psychological disease,
  • inflammatory/immunosuppressive disease,
  • drug allergy.
  • anti-inflammatory drugs, anti-histaminic, topic (application on the face) and systemic corticosteroids, narcotic, antidepressant, immunosuppressive drugs (with the except of hormonal treatment starting more than 1 year ago),
  • using of drugs or dietary supplements able to influence the test results in the investigator opinion.

研究组 & 干预措施

Nutriage SPF 30 day cream and Nutriage night cream

Experimental

Application of the study products (day cream at the morning and night cream at the evening), for an uninterrupted period of 3 months.

干预措施: Nutriage SPF 30 day cream and Nutriage night cream (Difa Cooper S.p.a, Italy) (Other)

结局指标

主要结局

Change of skin resistance to pinching clinical score

时间窗: Baseline visit (T0), 1 month (T1), 2 months (T2), 3 months (T3)

The evaluation was performed at level of cheek (malar region) according to the following score: 0 = very important 1. = important 2. = moderate 3. = weak 4. = very weak

Change of skin recovery after pinching clinical score

时间窗: Baseline visit (T0), 1 month (T1), 2 months (T2), 3 months (T3)

The evaluation was performed at level of cheek (malar region) according to the following score: 0 = very important 1. = important 2. = moderate 3. = weak 4. = very weak

Change of skin dryness clinical score

时间窗: Baseline visit (T0), 1 month (T1), 2 months (T2), 3 months (T3)

Clinical evaluation of skin dryness was performed according to the following score: 0 = very hydrated skin 1. = hydrated skin 2. = normal skin 3. = kindly dry skin 4. = dry skin 5. = very dry skin

Change of wrinkles grade, around the eyes (Crow's feet)

时间窗: Baseline visit (T0), 1 month (T1), 2 months (T2), 3 months (T3)

Variation of wrinkles grade from baseline of the Glogau's reference photographic scale (visual score from 1-4) where: * Type 1: early wrinkles * Type 2: wrinkle in motion * Type 3: wrinkles at rest * Type 4: Only wrinkles

Change of wrinkles grade of nasolabial folds

时间窗: Baseline visit (T0), 1 month (T1), 2 months (T2), 3 months (T3)

Variation of wrinkles grade from baseline of the Lemperle's reference photographic scale (visual score from 1-6) where: * Grade 1: no wrinkles * Grade 2: just perceptible wrinkles * Grade 3: shallow wrinkles * Grade 4: moderately deep wrinkles * Grade 5: deep wrinkles, well-defined folds * Grade 6: very deep wrinkles, redundant fold

Change of skin surface microrelief's regularity

时间窗: Baseline visit (T0), 1 month (T1), 2 months (T2), 3 months (T3)

Variation of skin surface microrelief's regularity grade from baseline of cheek surface microrelief photographic scale where: * Grade 1:very regular * Grade 2: regular * Grade 3: irregular * Grade 4: very irregular.

Change of vascular and pigmentary homogeneity clinical score

时间窗: Baseline visit (T0), 1 month (T1), 2 months (T2), 3 months (T3)

Homogeneity grade was determined according to specific reference clinical and photographic scales and to the following clinical score: 0 = very homogeneous 1. = homogeneous 2. = quite not homogeneous 3. = not homogeneous 4. = very not homogeneous 5. = marked not homogeneous

Change of skin resistance to traction clinical score

时间窗: Baseline visit (T0), 1 month (T1), 2 months (T2), 3 months (T3)

The evaluation was performed at level of cheek (malar region) according to the following score: 0 = very important 1. = important 2. = moderate 3. = weak 4. = very weak

次要结局

  • Change of roughness profilometric parameters(Baseline visit (T0), 1 month (T1), 2 months (T2), 3 months (T3))
  • Photographic documentation (3D pictures)(Baseline visit (T0), 1 month (T1), 2 months (T2), 3 months (T3))

研究者

发起方
Derming SRL
申办方类型
Other
责任方
Principal Investigator
主要研究者

Adele Sparavigna

Medical Doctor

Derming SRL

研究点 (2)

Loading locations...

相似试验